Cytokine Signalling Forum
Discussing axSpA: JAKi cycling and long-term safety of bimekizumab in patients with axSpA or PsA
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:32:17
- Mas informaciones
Informações:
Sinopsis
Join Dr Sofia Ramiro and cohosts Professors Atul Deodhar, Hideto Kameda, and Xenofon Baraliakos for the latest episode of the discussing axSpA podcast on The Immune-Mediated Inflammatory Disease Forum, where they discuss the latest updates in axSpA. In this episode, our faculty discusses two papers: the first assesses switching to secukinumab or cycling with other TNF inhibitors, and the second investigates long-term safety of bimekizumab in adult patients with axSpA or PsA.
